Liquid chromatographic determination of mycophenolic acid and its metabolites in human kidney transplant plasma: Pharmacokinetic application

被引:25
作者
Elbarbry, Fawzy A. [1 ]
Shoker, Ahmed S. [1 ]
机构
[1] Univ Saskatchewan, Royal Univ Hosp, Dept Med, Saskatoon, SK S7N 0W8, Canada
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2007年 / 859卷 / 02期
关键词
pharmacokinetics; mycophenolic acid; therapeutic drug monitoring; transplantation; HPLC assay; validation;
D O I
10.1016/j.jchromb.2007.09.036
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background and objective: Difference in the hydrophilic properties of mycophenolic acid metabolites makes it technically difficult to simultaneously determine their plasma levels in one analytical run. Therapeutic drug monitoring (TDM) for MPA ensures adequate MPA exposure levels to both prevent rejection and avoid related toxicity. One measure limitation for TDM for MPA is the availability of simple, rapid and reproducible method for determination of MPA derivatives. Method: Herein we report a single method to measure MPA and its metabolites using a gradient elution system in less than 10 min. We further tested applicability of our method in both stable and unstable renal transplant recipients with a wide range of levels. Results: Intra- and inter-day imprecision were less than 8% and 10%, respectively. Accuracy of the estimated concentrations ranges from 90% to 108%. Conclusion: Collectively these data show that the new method is reasonably accurate and precise for the simultaneous determination of MPA and its metabolites in human plasma. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:276 / 281
页数:6
相关论文
共 28 条
[1]   Simultaneous determination of free mycophenolic acid and its glucuronide in serum of patients under mycophenolate mophetil therapy by ion-pair reversed-phase liquid chromatography with diode array UV detection [J].
Aresta, A ;
Palmisano, F ;
Zambonin, CG ;
Schena, P ;
Grandaliano, G .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 810 (02) :197-202
[2]   Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection [J].
Atcheson, B ;
Taylor, PJ ;
Mudge, DW ;
Johnson, DW ;
Pillans, PI ;
Tett, SE .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 799 (01) :157-163
[3]   An isocratic high performance liquid chromatographic method for quantification of mycophenolic acid and its glucuronide metabolite in human serum using liquid-liquid extraction: Application to human pharmacokinetic studies [J].
Bahrami, Gholamreza ;
Mohammadi, Bahareh .
CLINICA CHIMICA ACTA, 2006, 370 (1-2) :185-190
[4]   HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material [J].
Bolon, M ;
Jeanpierre, L ;
El Barkil, M ;
Chelbi, K ;
Sauviat, M ;
Boulieu, R .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 36 (03) :649-651
[5]   Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites [J].
Brandhorst, Gunnar ;
Streit, Frank ;
Goetze, Sandra ;
Oellerich, Michael ;
Armstrong, Victor William .
CLINICAL CHEMISTRY, 2006, 52 (10) :1962-1964
[6]   Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration [J].
Bullingham, R ;
Monroe, S ;
Nicholls, A ;
Hale, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (04) :315-324
[7]   Clinical pharmacokinetics of mycophenolate mofetil [J].
Bullingham, RES ;
Nicholls, AJ ;
Kanmm, BR .
CLINICAL PHARMACOKINETICS, 1998, 34 (06) :429-455
[8]   Therapeutic drug measurement of mycophenolic acid derivatives in transplant patients [J].
Elbarbry, Fawzy A. ;
Shoker, Ahmed S. .
CLINICAL BIOCHEMISTRY, 2007, 40 (11) :752-764
[9]  
*EUR MYC MOF COOP, 1995, LANCET, P1321
[10]   Mycophenolate mofetil in renal allograft recipients - A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection [J].
Halloran, P ;
Mathew, T ;
Tomlanovich, S ;
Groth, C ;
Hooftman, L ;
Barker, C .
TRANSPLANTATION, 1997, 63 (01) :39-47